IM Cannabis Corp. is an MCO in the medical and adult-use recreational cannabis sector. It operates principally in Israel, Germany and Canada. IM Cannabis Corp. is headquartered in Israel.
| Revenue (Most Recent Fiscal Year) | $39.44M |
| Net Income (Most Recent Fiscal Year) | $-7.72M |
| PE Ratio (Current Year Earnings Estimate) | -- |
| PE Ratio (Trailing 12 Months) | -- |
| PEG Ratio (Long Term Growth Estimate) | -- |
| Price to Sales Ratio (Trailing 12 Months) | 0.30 |
| Price to Book Ratio (Most Recent Quarterly Book Value per Share) | 2.94 |
| Price to Cash Ratio (Most Recent Annual Cash Flow per Share) | -- |
| Pre-Tax Margin (Trailing 12 Months) | -11.97% |
| Net Margin (Trailing 12 Months) | -9.10% |
| Return on Equity (Trailing 12 Months) | -122.96% |
| Return on Assets (Trailing 12 Months) | -11.69% |
| Current Ratio (Most Recent Fiscal Quarter) | 0.72 |
| Quick Ratio (Most Recent Fiscal Quarter) | 0.59 |
| Debt to Common Equity (Most Recent Fiscal Quarter) | 0.10 |
| Inventory Turnover (Trailing 12 Months) | 9.49 |
| Book Value per Share (Most Recent Fiscal Quarter) | $1.03 |
| Earnings per Share (Most Recent Fiscal Quarter) | -- |
| Earnings per Share (Most Recent Fiscal Year) | -- |
| Diluted Earnings per Share (Trailing 12 Months) | $-0.64 |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Drug Manufacturers - Specialty & Generic |
| Common Shares Outstanding | 4.04M |
| Free Float | -- |
| Market Capitalization | $11.77M |
| Average Volume (Last 20 Days) | 0.15M |
| Beta (Past 60 Months) | 2.19 |
| Percentage Held By Insiders (Latest Annual Proxy Report) | -- |
| Percentage Held By Institutions (Latest 13F Reports) | 7.68% |
| Annual Dividend (Based on Last Quarter) | $0.00 |
| Dividend Yield (Based on Last Quarter) | 0.00% |